Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Diabetic Neuropathies: early-phase trial registry

1 of 9 indexed Diabetic Neuropathies trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 1 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Diabetic Neuropathies: 9 US clinical trials tracked, 1 recruiting.

Diabetic Neuropathies is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Pure Green, running 1 of these trials.

Enrollment posture brief

Registry condition diabetic-neuropathies

OPEN 1 | RECR 11% | LATE 2 | EARLY 5 | RANK #1916 | SPON 1

Nearest open-share peer: Alcohol Use Disorders (11% recruiting · 9 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%Diabetic Neuropathies (this)11%
Open-enrollment share among volume-matched conditions near Diabetic Neuropathies

Diabetic Neuropathies lists 1 open slots (11% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diabetic Neuropathies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diabetic Neuropathies is recruiting below its size-band peers.

    1 of 9 indexed trials (11.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Diabetic Neuropathies trials is spread across many organizations.

    Pure Green accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Diabetic Neuropathies enrolment sits around 331 participants.

    Median target enrolment is 331 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.

  4. Diabetic Neuropathies research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 23Phase 32

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 3
Phase 3 2

Top Sponsors

Named interventions

Most-linked intervention names on Diabetic Neuropathies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

SPM 927 Drug
1 trials
Cebranopadol 600 µg Drug
1 trials
Cebranopadol 300 µg Drug
1 trials
Cebranopadol 100 µg Drug
1 trials
Ruboxistaurin mesylate Drug
1 trials
TAK-583 Drug
1 trials
Salsalate Oral Tablet Drug
1 trials
Fish Oil Concentrate, 1000 Mg Oral Capsule Drug
1 trials

US sites by state

Facility locations filed on Diabetic Neuropathies trials. A trial with sites in several states counts in each.

Illinois 4 trials
Idaho 3 trials
Florida 3 trials
California 3 trials
Arizona 3 trials
Massachusetts 2 trials
Georgia 2 trials
Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diabetic Neuropathies page

9 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Diabetic Neuropathies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Pure Green sponsors the most Diabetic Neuropathies trials on record, review their full trial history before evaluating a specific study. See Pure Green's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Neuropathies condition card totals 9 registered trials; most-linked intervention SPM 927; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.